.Zevra Therapies' uncommon health condition drug seems to be on the pathway to permission this fall ...
.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has gone a $230 million ...
.After more than twenty years of deal with neurodegenerative diseases, Swiss biotech a/c Immune syst...
.GSK has junked a phase 2 human papillomavirus (HPV) vaccine coming from its own pipe after making a...
.OS Therapies are going to provide on the NYSE American inventory swap today using a $6.4 million IP...
.ALX Oncology's phase 2 stomach cancer cells response cost has diminished. After finding its CD47 bl...
.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has disappointed expectations, tr...
.While Biogen's pharma peers are actually searching for late-stage assets with little bit of threat,...
.Instil Biography has been a biotech in search of a pipeline after it junked its own lead resources ...
.Biogen has actually restored civil liberties to a very early Alzheimer's disease plan to Denali The...